Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease

Sponsor
Rhode Island Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05599425
Collaborator
(none)
40
2
13

Study Details

Study Description

Brief Summary

Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that educates people about Alzheimer's disease risk factors and helps them understand how their personal health beliefs may prevent them from making long-lasting lifestyle changes. The goal is to help people sustain health behavior changes to prevent or delay the onset of Alzheimer's disease and related dementias.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Enhanced Healthy Living Education
  • Behavioral: Basic Healthy Living Education
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Development of a Personalized Intervention to Motivate Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Healthy Living Education

The basic healthy living education intervention is a 24-session program (two sessions/week for 12 weeks) designed to educate participants about major modifiable risk factors for Alzheimer's disease. The first session each week is didactic, intended to increase knowledge about each Alzheimer's disease risk factor. The second session involves repetition and practice of didactic material as well as strategizing cues to action

Behavioral: Basic Healthy Living Education
24-session healthy living education program

Experimental: Enhanced Healthy Living Education

The enhanced healthy living education intervention will include the same didactic content as the basic HLE course for the first session each week. The second session will focus on personal health beliefs and how they affect specific health behaviors. This may include discussing perceived benefits, troubleshooting barriers to action, making specific action plans, and implementing natural reward systems to bolster self-efficacy.

Behavioral: Enhanced Healthy Living Education
24-session healthy living education program, with enhanced content about health beliefs and mechanisms of behavior change

Outcome Measures

Primary Outcome Measures

  1. Perceived Threat of Alzheimer's Disease Scale [baseline]

    7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat

  2. Perceived Threat of Alzheimer's Disease Scale [4 weeks]

    7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat

  3. Perceived Threat of Alzheimer's Disease Scale [8 weeks]

    7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat

  4. Perceived Threat of Alzheimer's Disease Scale [12 weeks (treatment endpoint)]

    7-item Likert-type scale assessing perceived likelihood, concern, and consequences of Alzheimer's disease; higher scores indicate greater perceived threat

  5. Dementia Awareness Questionnaire [baseline]

    self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness

  6. Dementia Awareness Questionnaire [4 weeks]

    self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness

  7. Dementia Awareness Questionnaire [8 weeks]

    self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness

  8. Dementia Awareness Questionnaire [12 weeks]

    self-report measure of knowledge of modifiable Alzheimer's disease risk factors; higher scores are associated with greater dementia awareness

  9. Generalized Self-Efficacy Scale [baseline]

    10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy

  10. Generalized Self-Efficacy Scale [4 weeks]

    10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy

  11. Generalized Self-Efficacy Scale [8 weeks]

    10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy

  12. Generalized Self-Efficacy Scale [12 weeks]

    10-item self-report questionnaire assessing belief in one's own abilities; higher scores indicate greater self-efficacy

Secondary Outcome Measures

  1. Mediterranean Diet Assessment Tool [baseline]

    14-item measure of adherence to a Mediterranean type diet; higher scores indicate greater diet adherence

  2. Mediterranean Diet Assessment Tool [12 weeks]

    14-item measure of adherence to a Mediterranean type diet; higher scores indicate greater diet adherence

  3. CHAMPS Activities Questionnaire for Older Adults [baseline]

    self-report measure of engagement in physical activities, tailored to older adult population; higher scores indicate greater engagement in physical activity

  4. CHAMPS Activities Questionnaire for Older Adults [12 weeks]

    self-report measure of engagement in physical activities, tailored to older adult population; higher scores indicate greater engagement in physical activity

  5. Florida Cognitive Activities Scale [baseline]

    25-item self-report measure about engagement in mentally stimulating activities; higher scores indicate greater cognitive activity

  6. Florida Cognitive Activities Scale [12 weeks]

    25-item self-report measure about engagement in mentally stimulating activities; higher scores indicate greater cognitive activity

  7. Perceived Stress Scale [baseline]

    10-item measure that assesses perceived stress; higher scores indicate greater perceived stress

  8. Perceived Stress Scale [4 weeks]

    10-item measure that assesses perceived stress; higher scores indicate greater perceived stress

  9. Perceived Stress Scale [8 weeks]

    10-item measure that assesses perceived stress; higher scores indicate greater perceived stress

  10. Perceived Stress Scale [12 weeks]

    10-item measure that assesses perceived stress; higher scores indicate greater perceived stress

  11. Positive and Negative Affect Schedule [baseline]

    20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively

  12. Positive and Negative Affect Schedule [4 weeks]

    20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively

  13. Positive and Negative Affect Schedule [8 weeks]

    20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively

  14. Positive and Negative Affect Schedule [12 weeks]

    20-item measure that assesses positive and negative emotional experiences, yielding two scores; higher scores indicate greater experience of positive or negative experiences, respectively

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age 45-69 years

  • normal cognition (Minnesota Cognitive Acuity Scale > 52)

  • English language fluency

  • at least two of the following: i) BMI > 24.9; ii) systolic blood pressure > 125 mmHg;

  1. LDL cholesterol > 115 mg/dL; iv) HbA1C > 6.0%; v) at least one APOE ε4 allele;
  2. first-degree relative with AD.
Exclusion Criteria:
  • history of serious mental illness (i.e., schizophrenia, bipolar disorder)

  • history of neurologic or neurodevelopmental disorder

  • current alcohol or drug use disorder based on self-report

  • current enrollment in an AD prevention clinical trial.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Rhode Island Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT05599425
Other Study ID Numbers:
  • R21AG075328
First Posted:
Oct 31, 2022
Last Update Posted:
Oct 31, 2022
Last Verified:
Oct 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2022